Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysis

•This meta-analysis compared the efficacy of ICIs between younger and older patients.•ICIs significantly improved OS in both younger (HR, 0.75) and older (HR, 0.73) groups.•An improvement in PFS was observed in younger (HR, 0.58) and older (HR, 0.77) patients.•In the PD-1 inhibitor subgroup, a signi...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Cancer treatment reviews Ročník 45; s. 30 - 37
Hlavní autori:	Nishijima, Tomohiro F., Muss, Hyman B., Shachar, Shlomit S., Moschos, Stergios J.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Netherlands Elsevier Ltd 01.04.2016
Predmet:	Age Age Factors Aging - immunology Antibodies, Monoclonal - classification Antibodies, Monoclonal - immunology Antibodies, Monoclonal - pharmacology Antineoplastic Agents - classification Antineoplastic Agents - immunology Antineoplastic Agents - pharmacology Disease-Free Survival Hematology, Oncology and Palliative Medicine Humans Immune checkpoint inhibitor Immunosenescence Meta-analysis Neoplasms - drug therapy Neoplasms - immunology Overall survival Progression-free survival Randomized Controlled Trials as Topic Systematic review Treatment Outcome Immune checkpoint inhibitor Immunosenescence Systematic review Overall survival Progression-free survival Age Meta-analysis
ISSN:	0305-7372, 1532-1967, 1532-1967
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!